๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Midazolam - Medicines in Ireland

23 authorised products containing Midazolam, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 23 authorised medicines
MedicineActive substanceLicence holderStatus
BUCCOLAM 10 mg oromucosal solution
EU/1/11/709/004
Midazolam Laboratorios Lesvi, S.L. โ€”
BUCCOLAM 2.5 mg oromucosal solution
EU/1/11/709/001
Midazolam Laboratorios Lesvi, S.L. โ€”
BUCCOLAM 5 mg oromucosal solution
EU/1/11/709/002
Midazolam Laboratorios Lesvi, S.L. โ€”
BUCCOLAM 7.5 mg oromucosal solution
EU/1/11/709/003
Midazolam Laboratorios Lesvi, S.L. โ€”
Epistatus 10 mg oromucosal solution
PA20595/002/001
Midazolam SERB S.A. Not marketed
Epistatus 2.5 mg oromucosal solution
PA20595/002/002
Midazolam SERB S.A. Not marketed
Epistatus 5 mg oromucosal solution
PA20595/002/003
Midazolam SERB S.A. Not marketed
Epistatus 7.5 mg oromucosal solution
PA20595/002/004
Midazolam SERB S.A. Not marketed
Midazolam 1 mg/ml solution for injection in pre-filled syringe
PA1968/017/001
Midazolam Laboratoire Aguettant Marketed
Midazolam 1 mg/ml Solution for Injection or Infusion
PA2315/063/001
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 1 mg/ml solution for injection/infusion
PA2165/012/002
Midazolam AS Kalceks โ€”
Midazolam 1 mg/ml solution for injection/infusion
PA1968/017/002
Midazolam Laboratoire Aguettant Marketed
Midazolam 1 mg/ml solution for injection/infusion in pre-filled syringe
PA2315/220/001
Midazolam Accord Healthcare Ireland Ltd. Not marketed
Midazolam 2 mg/ml Solution for injection or infusion
PA2315/063/005
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 5 mg/ml Solution for injection or infusion
PA2315/063/006
Midazolam Accord Healthcare Ireland Ltd. Marketed
Midazolam 5 mg/ml Solution for Injection or Infusion
PA2315/063/002
Midazolam Accord Healthcare Ireland Ltd. Not marketed
Midazolam 5 mg/ml solution for injection/infusion
PA2165/012/001
Midazolam AS Kalceks โ€”
Midazolam 5 mg/ml solution for injection/infusion
PA1968/017/003
Midazolam Laboratoire Aguettant Marketed
Midazolam Rowa 10 mg oromucosal solution
PA0074/099/004
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 2.5 mg oromucosal solution
PA0074/099/001
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 5 mg oromucosal solution
PA0074/099/002
Midazolam Rowa Pharmaceuticals Limited, Marketed
Midazolam Rowa 7.5 mg oromucosal solution
PA0074/099/003
Midazolam Rowa Pharmaceuticals Limited, Marketed
Ozalin 2 mg/ml oral solution in single-dose container
PA25340/002/001
Midazolam Istituto Gentili S.r.l. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.